Six analogs of 2‐amino‐5‐(3‐anilinopropyl)‐6‐methyl‐4‐pyrimidinol (II) with modifications in the anilino group have been synthesized in order to shed light on the mode of binding of the anilino group to dihydrofolic reductase and thymidylate synthetase. Replacement of the anilino group of II with n ‐butylamino (XI) led to great decrease in binding, indicating that the anilino group did not bind to these enzymes in the protonated form. Replacement of the anilino group of II with benzyl gave a compound (XIIb) which was a 26‐fold and 1.5‐fold better inhibitor of dihydrofolic reductase and thymidylate synthetase, respectively; these results indicated that the NH portion of the anilino group contributed less to the enzyme binding than did the benzene ring, and that the latter probably was bound as an electron acceptor in a charge‐transfer complex to an electron‐rich locus on the enzyme. Further evidence was also obtained that the benzene ring was complexing as an electron acceptor by placement of electron‐donating or electron‐withdrawing groups on the p ‐positions of anilino group, and by N‐acetylation of the anilino group.
No takes yet. Share an insight, caveat, or question.
Baker et al. (1964) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: